Gene-specific treatment approaches in muscle diseases
Gene-specific treatment for hereditary muscle diseases has made great progress in recent years. The pathomechanisms of many of these diseases could be decrypted using molecular genetic techniques, paving the way for disease-modifying treatment options. A milestone was undoubtedly the successful tran...
Saved in:
Published in | Nervenarzt Vol. 91; no. 4; pp. 318 - 323 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | German |
Published |
Germany
01.04.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Gene-specific treatment for hereditary muscle diseases has made great progress in recent years. The pathomechanisms of many of these diseases could be decrypted using molecular genetic techniques, paving the way for disease-modifying treatment options. A milestone was undoubtedly the successful translation of the antisense oligonucleotide (ASO) technology into clinical practice, with gene-specific ASOs being approved for the first time in 2016 for the treatment of spinal muscular atrophy and Duchenne muscular dystrophy. This article reviews recent developments in the field of antisense and gene therapies for hereditary muscle diseases. |
---|---|
AbstractList | Gene-specific treatment for hereditary muscle diseases has made great progress in recent years. The pathomechanisms of many of these diseases could be decrypted using molecular genetic techniques, paving the way for disease-modifying treatment options. A milestone was undoubtedly the successful translation of the antisense oligonucleotide (ASO) technology into clinical practice, with gene-specific ASOs being approved for the first time in 2016 for the treatment of spinal muscular atrophy and Duchenne muscular dystrophy. This article reviews recent developments in the field of antisense and gene therapies for hereditary muscle diseases. |
Author | Lehmann Urban, Diana Schneider, Ilka |
Author_xml | – sequence: 1 givenname: Diana surname: Lehmann Urban fullname: Lehmann Urban, Diana email: diana.lehmann@rku.de organization: Neurologische Universitätsklinik, Universitäts- und Rehabilitationskliniken Ulm, Oberer Eselsberg 45, 89081, Ulm, Deutschland. diana.lehmann@rku.de – sequence: 2 givenname: Ilka surname: Schneider fullname: Schneider, Ilka organization: Neurologie Klinikum St. Georg, Leipzig, Deutschland |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32076754$$D View this record in MEDLINE/PubMed |
BookMark | eNo1jz1PwzAYhC0Eoh_wBxhQRhbDObbreEQVFKRKLDBHrvNaBCVpyJsM_HsiUaa74dGju5U4744dCXGjcK8A98CAUlYihwQKB1mciaUyWksYuIVYMX9hBh1wKRY6h9s4a5bC7qgjyT3FOtUxGwcKY0vdmIW-H44hfhJndZe1E8eGsqpmCkx8JS5SaJiuT7kWH89P79sXuX_bvW4f97JXRo0yWV0YH4qQkvcbDZqLiR6pSAn5weUqWGUCNFXmYKOpKjh461VMuYJKei3u_rzzlu-JeCzbmiM1TejoOHGZa-sNYGb5Wtye0OnQUlX2Q92G4af8v6p_AVh2VUc |
ContentType | Journal Article |
DBID | NPM 7X8 |
DOI | 10.1007/s00115-020-00870-8 |
DatabaseName | PubMed MEDLINE - Academic |
DatabaseTitle | PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Genspezifische Therapieansätze bei Muskelerkrankungen |
EISSN | 1433-0407 |
EndPage | 323 |
ExternalDocumentID | 32076754 |
Genre | English Abstract Journal Article Review |
GroupedDBID | -5E -5G -BR -EM -Y2 -~C .86 .GJ .VR 06C 06D 0R~ 0VY 1N0 1SB 2.D 203 29M 29~ 2J2 2JN 2JY 2KG 2LR 2P1 2VQ 2~H 30V 3O- 4.4 406 408 409 40D 40E 53G 5GY 5VS 67Z 6NX 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIVO ABJNI ABJOX ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABULA ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACIPQ ACKNC ACMDZ ACMLO ACOKC ACOMO ACSNA ACZOJ ADHHG ADHIR ADINQ ADKNI ADKPE ADQRH ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BDATZ BGNMA CAG COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GXS H13 HF~ HG5 HG6 HMJXF HQYDN HRMNR HVGLF HZ~ IHE IJ- IKXTQ IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KPH LAS LLZTM M4Y MA- N2Q N9A NB0 NPM NPVJJ NQJWS NU0 O9- O93 O9I O9J OAM P9S PF0 PT4 QOK QOR QOS R89 R9I RIG ROL RPX RRX RSV S16 S1Z S27 S37 S3B SAP SDH SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 TSG TSK TSV TT1 TUC U2A U9L UG4 UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 X7J YLTOR Z45 ZGI ZMTXR ZOVNA ~S- 7X8 |
ID | FETCH-LOGICAL-p141t-f53849a8aff99630eaff4c90f8ff02b721a514a03ed4b5c4dd0709591cf2101f3 |
IngestDate | Fri Oct 25 22:21:55 EDT 2024 Wed Oct 16 00:45:17 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Cell-based treatment Antisense oligonucleotide Gene therapy Myotonic dystrophy 1 Muscular dystrophy, Duchenne |
Language | German |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-p141t-f53849a8aff99630eaff4c90f8ff02b721a514a03ed4b5c4dd0709591cf2101f3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
PMID | 32076754 |
PQID | 2359400496 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_2359400496 pubmed_primary_32076754 |
PublicationCentury | 2000 |
PublicationDate | 2020-Apr 20200401 |
PublicationDateYYYYMMDD | 2020-04-01 |
PublicationDate_xml | – month: 04 year: 2020 text: 2020-Apr |
PublicationDecade | 2020 |
PublicationPlace | Germany |
PublicationPlace_xml | – name: Germany |
PublicationTitle | Nervenarzt |
PublicationTitleAlternate | Nervenarzt |
PublicationYear | 2020 |
SSID | ssj0007700 |
Score | 2.250746 |
SecondaryResourceType | review_article |
Snippet | Gene-specific treatment for hereditary muscle diseases has made great progress in recent years. The pathomechanisms of many of these diseases could be... |
SourceID | proquest pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 318 |
Title | Gene-specific treatment approaches in muscle diseases |
URI | https://www.ncbi.nlm.nih.gov/pubmed/32076754 https://search.proquest.com/docview/2359400496 |
Volume | 91 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS8MwFA46QfYi3p03Kvg2ImmTrs2jt6Gie9HB3kaaJkx03djlxV_vSdJ2FR2oL6Wko2X52i_ntN93DkLnccxYFNEIExpJzKjiWMhEY-23FJNa0FRYlW-ndddlD72wt-iZad0ls-RCfvzoK_kPqjAGuBqX7B-QLU8KA7AP-MIWEIbtrzA2NaOx8UoavU9VM54XCrdiq-ZwPpXGHuU-xUyr4WjH6h3F5KMUvzyqwVBkWbM7Sdyr0Ru4f0rqfpaDzBTGsjDfv7-J6kuDgFS0JsoRHaMUBl3H2YIJXd-sHHFWoTXqOPIb3TqFhe1eZnzexqMOzz_-8mOYsvHQAkADYkrHsMXSUwoCi0OraC0AxohraO2yfXXVKRfVKCIk9zxZ5-O3S9bRenGS5cmCDRpeNtFGHu17lw66LbSSqm20_pTrGXZQ-AVBr0TQWyDovWaeQ9ArENxF3fbty_UdzhtZ4LHP_BnWsKowLmKhNaSXlCjYYZITHWtNggSScAFxqyBUpSwJJUtTIGIecl9qyMh9TfdQLRtl6gB53NfcNFVViUiZjGIeiwRCPq19HUImKRrorPjvfSAK8_VHZGo0n_YDGnJD2LzVQPtuUvpjV9GkX8zc4dIjR6i-uI-OUW02masTCMdmyWkO1SfAqTKO |
link.rule.ids | 315,783,787,27938,27939 |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gene-specific+treatment+approaches+in+muscle+diseases&rft.jtitle=Nervenarzt&rft.au=Lehmann+Urban%2C+Diana&rft.au=Schneider%2C+Ilka&rft.date=2020-04-01&rft.eissn=1433-0407&rft.volume=91&rft.issue=4&rft.spage=318&rft_id=info:doi/10.1007%2Fs00115-020-00870-8&rft_id=info%3Apmid%2F32076754&rft.externalDocID=32076754 |